Cerner Co. (NASDAQ:CERN) saw unusually large options trading activity on Tuesday. Investors acquired 5,409 put options on the stock. This is an increase of approximately 2,293% compared to the average daily volume of 226 put options.

In other Cerner news, CFO Marc G. Naughton sold 60,000 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $70.64, for a total transaction of $4,238,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Clifford W. Illig sold 140,000 shares of the stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the transaction, the chief executive officer now directly owns 1,229,719 shares of the company’s stock, valued at approximately $80,571,188.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 784,000 shares of company stock valued at $51,926,960. 13.11% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the stock. Advisory Services Network LLC raised its holdings in Cerner by 4.4% in the second quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock valued at $110,000 after acquiring an additional 70 shares in the last quarter. Fuller & Thaler Asset Management Inc. acquired a new stake in Cerner in the third quarter valued at approximately $121,000. Cerebellum GP LLC acquired a new stake in Cerner in the fourth quarter valued at approximately $127,000. Steward Partners Investment Advisory LLC acquired a new stake in Cerner in the third quarter valued at approximately $128,000. Finally, Fort Pitt Capital Group LLC acquired a new stake in Cerner in the third quarter valued at approximately $205,000. 81.99% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have recently commented on the stock. SunTrust Banks lowered shares of Cerner from a “buy” rating to a “hold” rating in a research note on Tuesday, January 16th. They noted that the move was a valuation call. Zacks Investment Research lowered shares of Cerner from a “buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Royal Bank of Canada reissued a “buy” rating on shares of Cerner in a research note on Wednesday, October 25th. JPMorgan Chase & Co. lowered shares of Cerner from an “overweight” rating to a “neutral” rating in a research note on Friday, October 27th. Finally, Leerink Swann reissued a “hold” rating on shares of Cerner in a research note on Saturday, November 25th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have given a buy rating to the stock. Cerner presently has a consensus rating of “Hold” and a consensus price target of $67.05.

Shares of Cerner (CERN) opened at $61.31 on Friday. The firm has a market cap of $20,350.44, a P/E ratio of 23.86, a P/E/G ratio of 1.80 and a beta of 0.90. Cerner has a 1-year low of $51.26 and a 1-year high of $73.86. The company has a quick ratio of 2.75, a current ratio of 3.01 and a debt-to-equity ratio of 0.11.

Cerner (NASDAQ:CERN) last issued its earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.61 by ($0.03). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $0.61 EPS. equities analysts forecast that Cerner will post 2.47 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This article was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://theolympiareport.com/2018/02/11/traders-buy-high-volume-of-cerner-put-options-cern.html.

About Cerner

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.